Article

Access to Treatments for Terminally Ill Patients

C.R.S. § 25-45-101— Short title
C.R.S. § 25-45-102— Legislative declaration
C.R.S. § 25-45-103— Definitions
C.R.S. § 25-45-104— Drug manufacturers
C.R.S. § 25-45-105— Action against health-care provider’s license or medicare certification prohibited
C.R.S. § 25-45-106— Access to investigational drugs, biological products, and devices
C.R.S. § 25-45-107— No cause of action created
C.R.S. § 25-45-108— Effect on health-care coverage